Institutional investors purchased a net $2.3 million shares of RGEN during the quarter ended December 2013, and now own 80.54% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 557.0 Thousand shares of Repligen Corp
FIDELITY MANAGEMENT & RESEARCH C... Bought 455.8 Thousand shares of Repligen Corp
WALL STREET ASSOCIATES LLC Bought 408.8 Thousand shares of Repligen Corp